AstraZeneca in drive to slash costs
481177
Hostile environment prompts root and branch review. Exanta unlikely to win US approval in near future. By Stephen Foley. AstraZeneca, the UK&#39;s number two pharmaceuticals company, has launched a &quot;root and branch
57452
Shares in Anglo-Swedish drug giant AstraZeneca drop more than 8% in value after the failure of its Iressa drug in a major clinical trial.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
172149
TOPEKA - Kansans will be able to buy lower-cost prescription drugs from Canada and Europe under a program Gov. Kathleen Sebelius outlined this morning.
173862
Ten pharmaceutical companies said on Tuesday that they were joining a program to cut the prices of prescription drugs for the uninsured.
209626
Cancer drug distributors are trying to charge storage and handling fees to the makers of the drugs, a move some consumer groups worry could undermine parts of the Medicare prescription benefit law meant to curb pricing abuses.
594552
LONDON (CBS.MW) -- Pharmaceutical maker AstraZeneca (UK:AZN) (AZN) said it&#39;s investing 75 million British pounds ($139 million) in cash for a 19.9 percent stake in UK biotech group Cambridge Antibody Technology (UK:CAT) (CATG) as part of a five year, R&amp;D
764957
SHARES in drugs giant AstraZeneca bounced back having slumped to a 19-month low earlier today as US regulators formally blocked the launch of its new blood-thinning treatment Exanta.
257416
LONDON The British government said Wednesday that it had struck an agreement with the pharmaceutical industry to cut prescription drug prices by 7 percent at the end of the year, saving more than Â£1.
567272
The company teams up with AstraZeneca to bring its antibiotic to worldwide markets.
405385
Pharmaceutical companies launched an effort yesterday to provide significant price discounts for 275 brand-name drugs to 36 million Americans who lack prescription drug coverage.
356288
By Rosie Murray-West, City Correspondent (Filed: 14/09/2004). Astrazeneca shares plummeted yesterday as investors and analysts digested the pharmaceutical giant&#39;s announcement over potential blockbuster drug Exanta.
510581
AstraZeneca Plc has won US approval to market its Nexium ulcer pill as a treatment that reduces the risk of ulcers developing in patients on non-steroidal anti-inflammatory drugs, it said on Monday.
471781
The company is ready to handle competition from generics.
719897
The move appeared to be a competitive strategy and based on public concerns about the costs of new cancer drugs.
511170
Now might be a great time to load up on cutting-edge drugmakers.
62113
Patients in Wales are getting cheaper prescriptions -  the first step towards fulfilling a Labour promise to scrap them.